Foto de Chus Donlo


The 6th iPiE Forum Meeting was held in Barcelona during the 24th and 25th of April 2018

The 6th iPiE Forum Meeting was held in Barcelona during the 24th and 25th of April 2018, and counted with the presence of the participants of the iPiE Consortium. The Integrative Biomedical Informatics group and the PharmacoInformatics group of GRIB (IMIM-UPF) take part of this european project. The meeting was focused on progress to the development of guidance on how the established approaches and expert system from iPiE can be used in the intelligent testing of APIs at early stages in drug development; and to prioritise legacy APIs for further testing or assessment.

On the first day, an integration workshop was organised to define next steps towards the preparation of prioritisation guidelines. The workshop started with two parallel sessions, one attended by academia and other by industry representatives, including regulatory experts in both. The two groups were allowed for an internal debate that led to concrete conclusions on necessities from both sides. In such way, later discussion on the integration and the alignment of further work of different stakeholders was deepened. The meeting also included the updates of Work Packages and the progress done in the past months.

The meeting was organised by Synapse and the GRIB (IMIM-UPF) and took place at the PRBB premises. The industrial partner of the project, Bayer, partly sponsored the meeting.

About the project: iPIE “Intelligence Led Assessment of Pharmaceuticals in the Environment", aims to develop a predictive framework that utilise existing information and in silico models to support more intelligent environmental testing of pharmaceuticals in development and to prioritise legacy pharmaceuticals for full environmental risk assessment and/or environmental (bio) monitoring. European project funded by IMI for the period 2015-2017.

Site Information